Shandong Buchang Pharmaceuticals Co., Ltd. (603858.SS)
- Previous Close
15.82 - Open
15.80 - Bid 15.82 x --
- Ask 15.84 x --
- Day's Range
15.77 - 15.89 - 52 Week Range
13.83 - 19.70 - Volume
3,456,900 - Avg. Volume
5,399,897 - Market Cap (intraday)
17.498B - Beta (5Y Monthly) 0.59
- PE Ratio (TTM)
-- - EPS (TTM)
-0.32 - Earnings Date --
- Forward Dividend & Yield 0.13 (0.84%)
- Ex-Dividend Date Aug 20, 2024
- 1y Target Est
--
Shandong Buchang Pharmaceuticals Co., Ltd. engages in the research and development, production, and sale of medicines in China. The company offers medicines to treat cardiac and cerebral vascular, urinary and digestive, respiratory, gynecological, and other diseases, as well as diabetes. Shandong Buchang Pharmaceuticals Co., Ltd. was founded in 1993 and is based in Heze, China.
www.buchang.com8,311
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: 603858.SS
View MorePerformance Overview: 603858.SS
Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 603858.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 603858.SS
View MoreValuation Measures
Market Cap
17.50B
Enterprise Value
19.32B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.52
Price/Book (mrq)
1.67
Enterprise Value/Revenue
1.73
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-2.49%
Return on Assets (ttm)
1.75%
Return on Equity (ttm)
-4.04%
Revenue (ttm)
11.78B
Net Income Avi to Common (ttm)
-293.31M
Diluted EPS (ttm)
-0.32
Balance Sheet and Cash Flow
Total Cash (mrq)
1.31B
Total Debt/Equity (mrq)
36.39%
Levered Free Cash Flow (ttm)
1.19B